Abstract

Neisseria meningitides represents a pathogen of great public health importance in both developed and developing countries. Resistance to some antimicrobial agents used either for therapy of invasive infections or for prophylaxis of case contacts has long been recognized. However, there is no data in relation with the circulating serotypes and antimicrobial resistance patterns of Neisseria meningitides in Ethiopia. Therefore; the aim of this study was to assess drug susceptibility patterns of Neisseria meningitides from asymptomatic carrier for all age group at Meskan and Mareko Districts, Gurage Zone, in the Southern Nations, Nationalities and Peoples Regional State Ethiopia. A Cross-sectional survey of an age-stratified population in Meskan and Mareko Districts, Gurage Zone, in the Southern Nations, Nationalities and Peoples Regional State in Ethiopia was conducted at AHRI as part of the MenAfricar project. A total of 4110 subjects were screened and from these 187 Neisseria meningitides positive isolates was selected for Antimicrobial susceptibility testing (AST). Antimicrobial susceptibility test was done on stored Neisseria meningitides isolates. The activities of ten antimicrobial agents used for treatment and prophylaxis of meningococcal disease were investigated. The AST was performed for Neisseria meningitides isolates according to the criteria of the CLSI guide line by disk diffusion method. Data were analysed by using SPSS version 20.0 software. From 187 isolates 8(4.28%) were serogroup X, 24(12.83%) were serogroup Y, 1(0.53%) were serogroup W135, and 154(82.35%) were non determinant (ND). Cotrimoxazol resistant were the highest accounting116(62%), Ciprofloxacine resistant were 112(60%), Cefotaxime resistant were 26(14%), Ceftriaxone resistant were 24(13%), Meropenenem resistantwere 21(11%), Minocycline resistant were 15(8%), Rifampine resistant were 149(7%), 10(5%) were resistant to Azithromycine, 7(4%) were resistant to Chloramphenicol and 6(3%) were resistant to Levofloxacin and 102(54.5%) isolates were resistance for more than one drug. So, it has beenconcluded that an antimicrobial susceptibility pattern of Neisseria meningitides among asymptomatic carriers is high and continued surveillance of meningococci for antimicrobial resistance is necessary to monitor early detection of changes in susceptibility patterns that might affect recommendations for chemoprophylaxis and treatment.

Highlights

  • Infections by Neisseria meningitides are significant causes of mortality and morbidity in young children and adolescents

  • Neisseria meningitides were isolated from all age groups

  • The prevalence of Neisseria meningitides in our study was 320(7.8%) from the total population we used it is comparable to the study conducted in Ethiopia by Bårnes GK, et al (10) in Arba Minch, southern Ethiopia 6.6%, in Burkina Faso 7.86% (11), in Turkey by Gazi H. et al 6.2% [1] and study conducted in Greece (7.2%) [12]

Read more

Summary

Introduction

Infections by Neisseria meningitides are significant causes of mortality and morbidity in young children and adolescents. American Journal of Health Research 2019; 7(1): 12-18 surround this organism and the types of diseases it causes. Group A and group C meningococci are frequently the cause of major epidemic disease, in underdeveloped countries and among the poorer segments of society, perhaps reflecting certain risk factors associated with transmission, such as crowding and poor sanitation. The organisms may be asymptomatically carried in the oropharynx and nasopharynx of a variable percentage of individuals, and the rate of carriage is related to several factors such as age, socioeconomic class, and the presence of actual disease in a community [1]. Neisseria meningitides is a common bacterial commensal of the human upper respiratory tract (nasopharynx) and an important and devastating human pathogen. The persistence of large serogroup A outbreaks in Africa, the emergence in different regions of serogroups Y, X, and W-135 in the past decade, and the persistence of serogroups B and C disease in many industrialized countries [2]

Objectives
Methods
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call